NO311402B1 - Farmasöytiske preparater for oral administrasjon av flavonoider og fremgangsmåte ved fremstilling derav - Google Patents
Farmasöytiske preparater for oral administrasjon av flavonoider og fremgangsmåte ved fremstilling derav Download PDFInfo
- Publication number
- NO311402B1 NO311402B1 NO19954455A NO954455A NO311402B1 NO 311402 B1 NO311402 B1 NO 311402B1 NO 19954455 A NO19954455 A NO 19954455A NO 954455 A NO954455 A NO 954455A NO 311402 B1 NO311402 B1 NO 311402B1
- Authority
- NO
- Norway
- Prior art keywords
- diosmin
- effervescent
- pharmaceutical composition
- granule
- flavonoids
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 9
- 229930003935 flavonoid Natural products 0.000 title claims abstract description 8
- 150000002215 flavonoids Chemical class 0.000 title claims abstract description 8
- 235000017173 flavonoids Nutrition 0.000 title claims abstract description 8
- 238000002360 preparation method Methods 0.000 title description 5
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 claims abstract description 33
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 claims abstract description 33
- 229960004352 diosmin Drugs 0.000 claims abstract description 33
- IGBKNLGEMMEWKD-UHFFFAOYSA-N diosmin Natural products COc1ccc(cc1)C2=C(O)C(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 IGBKNLGEMMEWKD-UHFFFAOYSA-N 0.000 claims abstract description 33
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000008187 granular material Substances 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000005469 granulation Methods 0.000 claims abstract description 9
- 230000003179 granulation Effects 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 239000002245 particle Substances 0.000 claims abstract description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims abstract description 4
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims abstract description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 241001093501 Rutaceae Species 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 2
- 238000009472 formulation Methods 0.000 abstract description 8
- 235000003599 food sweetener Nutrition 0.000 abstract description 3
- 239000003765 sweetening agent Substances 0.000 abstract description 3
- 239000000796 flavoring agent Substances 0.000 abstract description 2
- 239000000969 carrier Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000007938 effervescent tablet Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 241001516739 Platonia insignis Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 235000012751 sunset yellow FCF Nutrition 0.000 description 1
- 239000004173 sunset yellow FCF Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000001643 venotonic effect Effects 0.000 description 1
- 208000037997 venous disease Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrane Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9413336A FR2726469B1 (fr) | 1994-11-08 | 1994-11-08 | Composition pharmaceutique pour l'administration orale de flavonoides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO954455D0 NO954455D0 (no) | 1995-11-07 |
| NO954455L NO954455L (no) | 1996-05-09 |
| NO311402B1 true NO311402B1 (no) | 2001-11-26 |
Family
ID=9468588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19954455A NO311402B1 (no) | 1994-11-08 | 1995-11-07 | Farmasöytiske preparater for oral administrasjon av flavonoider og fremgangsmåte ved fremstilling derav |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0711560B1 (sv) |
| JP (1) | JP3022952B2 (sv) |
| KR (1) | KR960016901A (sv) |
| CN (1) | CN1131538A (sv) |
| AT (1) | ATE202480T1 (sv) |
| AU (1) | AU706027B2 (sv) |
| CA (1) | CA2162299C (sv) |
| CY (1) | CY2265B1 (sv) |
| DE (1) | DE69521477T2 (sv) |
| DK (1) | DK0711560T3 (sv) |
| ES (1) | ES2160145T3 (sv) |
| FI (1) | FI117123B (sv) |
| FR (1) | FR2726469B1 (sv) |
| GR (1) | GR3036244T3 (sv) |
| NO (1) | NO311402B1 (sv) |
| NZ (1) | NZ280418A (sv) |
| PT (1) | PT711560E (sv) |
| ZA (1) | ZA959473B (sv) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1011151A3 (fr) * | 1997-05-13 | 1999-05-04 | Jose Remacle | Utilisation d'une composition pharmaceutique dans le traitement et/ou la prevention de l'ischemie. |
| US6350470B1 (en) * | 1998-04-29 | 2002-02-26 | Cima Labs Inc. | Effervescent drug delivery system for oral administration |
| JP4273277B2 (ja) * | 1999-06-30 | 2009-06-03 | 大塚製薬株式会社 | オリゴ糖補給組成物 |
| JP2001158796A (ja) * | 1999-11-30 | 2001-06-12 | Toyo Seito Kk | α−グルコシルジオスミンの製造方法及びフラボノイド組成物 |
| FR2845597B1 (fr) * | 2002-10-11 | 2005-03-11 | Innothera Lab Sa | Formulation orale seche contenant de la diosmine sous forme pharmaceutique de comprime a croquer |
| CN1717227A (zh) * | 2002-10-24 | 2006-01-04 | 伊穆法姆公司 | 含类黄酮和薄荷醇的药物组合物 |
| AT501682A1 (de) | 2005-01-14 | 2006-10-15 | Hermine Dr Engl | Verfahren zur herstellung einer wirkstoffmischung |
| ITMI20050517A1 (it) | 2005-03-30 | 2006-09-30 | Therapicon Srl | Composizione farmaceutica di una tipica frazione microcristallina di flavonoidi |
| ITMI20051942A1 (it) * | 2005-10-14 | 2007-04-15 | S I I T S R L Servizio Interna | Composizioni galattogeniche a base di silimarina |
| WO2007062415A1 (en) * | 2005-11-26 | 2007-05-31 | Grinrx | Corporeal delivery of carotenoids |
| MX2007011002A (es) * | 2007-09-07 | 2009-03-09 | World Trade Imp Export Wtie Ag | Composicion farmaceutica que comprende la combinacion de diversos agentes venotonicos y vasoprotectores para el tratamiento de la insuficiencia venosa cronica. |
| CA2769278A1 (en) * | 2009-08-10 | 2011-02-17 | Stokely-Van Camp, Inc. | Method for suspending a flavonoid in a beverage |
| MD3987C2 (ro) * | 2009-09-03 | 2010-07-31 | Георге АНГЕЛИЧ | Utilizare a Diosminei pentru tratamentul cirozei hepatice avansate asociate cu insuficienţă cardiacă |
| MD3986C2 (ro) * | 2009-09-23 | 2010-07-31 | Георге АНГЕЛИЧ | Utilizare a Diosminei pentru tratamentul gastropatiilor portale în ciroza hepatică |
| MD4231C1 (ro) * | 2012-11-08 | 2014-01-31 | Георге АНГЕЛИЧ | Remediu medicamentos pe bază de troxerutin şi carbazocrom pentru tratamentul gastropatiilor portale în ciroza hepatică |
| MD4232C1 (ro) * | 2012-11-08 | 2014-01-31 | Георге АНГЕЛИЧ | Remediu medicamentos pe bază de troxerutin şi carbazocrom pentru tratamentul cirozei hepatice avansate asociate cu insuficienţă cardiacă |
| FR2999934B1 (fr) | 2012-12-21 | 2015-02-20 | Servier Lab | Composition pharmaceutique sous la forme d'une suspension orale comprenant une fraction flavonoique et de la gomme xanthane |
| AU2015316552C1 (en) | 2014-09-17 | 2018-08-23 | Steerlife India Private Limited | Effervescent composition and method of making it |
| US11219594B2 (en) | 2015-12-12 | 2022-01-11 | Steerlife India Private Limited | Effervescent compositions of metformin and processes for preparation thereof |
| FR3083980B1 (fr) * | 2018-07-20 | 2021-04-16 | Servier Lab | Composition pharmaceutique sous la forme d'un comprime a croquer de diosmine ou d'une fraction flavonoique |
| US10639294B2 (en) | 2018-10-02 | 2020-05-05 | Janssen Pharmaceutica Nv | Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide metabolite |
| US11304968B2 (en) | 2018-11-16 | 2022-04-19 | Janssen Pharmaceutica Nv | Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide |
| WO2021123341A1 (en) | 2019-12-20 | 2021-06-24 | Krka, D.D., Novo Mesto | Composition comprising diosmin |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR6967M (sv) * | 1968-01-22 | 1969-05-19 | ||
| JPS52156913A (en) * | 1976-06-21 | 1977-12-27 | Toko Yakuhin Kogyo Kk | Production of injectionable medicine |
| RO81345B1 (ro) * | 1980-07-28 | 1983-02-28 | Nicolae Oita | Medicament destinat insuficientei circulatorii periferice |
| WO1985003865A1 (en) * | 1984-03-01 | 1985-09-12 | Casley Smith John Royle | Treatment of high protein oedemas in animals |
| FR2577437A1 (fr) * | 1985-02-21 | 1986-08-22 | Corbiere Jerome | Nouveau procede de solubilisation des composes chimiques et les preparations aqueuses ainsi obtenues |
| IT1201149B (it) * | 1987-01-14 | 1989-01-27 | Indena Spa | Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche |
| FR2634376B1 (fr) * | 1988-07-21 | 1992-04-17 | Farmalyoc | Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation |
| FR2661610B1 (fr) * | 1990-05-02 | 1994-09-30 | Rhone Poulenc Sante | Nouvelle forme lyophilisee de la diosmine et sa preparation. |
| FR2661830B1 (fr) * | 1990-05-11 | 1992-09-04 | Corbiere Jerome | Nouvelle compositions pharmaceutiques a base de flavonoside. |
| FR2668705A1 (fr) * | 1990-11-06 | 1992-05-07 | Bouchara Sa | Nouvelles preparations dermiques a action phlebotonique et leur procede de preparation. |
-
1994
- 1994-11-08 FR FR9413336A patent/FR2726469B1/fr not_active Expired - Fee Related
-
1995
- 1995-11-06 FI FI955310A patent/FI117123B/sv not_active IP Right Cessation
- 1995-11-06 AU AU36695/95A patent/AU706027B2/en not_active Ceased
- 1995-11-07 ES ES95402476T patent/ES2160145T3/es not_active Expired - Lifetime
- 1995-11-07 AT AT95402476T patent/ATE202480T1/de active
- 1995-11-07 NZ NZ280418A patent/NZ280418A/en not_active IP Right Cessation
- 1995-11-07 CA CA002162299A patent/CA2162299C/fr not_active Expired - Fee Related
- 1995-11-07 DK DK95402476T patent/DK0711560T3/da active
- 1995-11-07 NO NO19954455A patent/NO311402B1/no not_active IP Right Cessation
- 1995-11-07 DE DE69521477T patent/DE69521477T2/de not_active Expired - Lifetime
- 1995-11-07 JP JP7288467A patent/JP3022952B2/ja not_active Expired - Fee Related
- 1995-11-07 EP EP95402476A patent/EP0711560B1/fr not_active Expired - Lifetime
- 1995-11-07 CN CN95118756A patent/CN1131538A/zh active Pending
- 1995-11-07 PT PT95402476T patent/PT711560E/pt unknown
- 1995-11-08 KR KR1019950040899A patent/KR960016901A/ko not_active Application Discontinuation
- 1995-11-08 ZA ZA959473A patent/ZA959473B/xx unknown
-
2001
- 2001-07-19 GR GR20010401093T patent/GR3036244T3/el unknown
-
2002
- 2002-04-12 CY CY0200016A patent/CY2265B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI955310A (sv) | 1996-05-09 |
| AU3669595A (en) | 1996-05-16 |
| CN1131538A (zh) | 1996-09-25 |
| FI117123B (sv) | 2006-06-30 |
| EP0711560B1 (fr) | 2001-06-27 |
| ZA959473B (en) | 1996-05-15 |
| EP0711560A1 (fr) | 1996-05-15 |
| KR960016901A (ko) | 1996-06-17 |
| CY2265B1 (en) | 2003-07-04 |
| JPH08208469A (ja) | 1996-08-13 |
| DE69521477T2 (de) | 2002-04-18 |
| NO954455L (no) | 1996-05-09 |
| GR3036244T3 (en) | 2001-10-31 |
| NZ280418A (en) | 1997-03-24 |
| DE69521477D1 (de) | 2001-08-02 |
| ATE202480T1 (de) | 2001-07-15 |
| CA2162299A1 (fr) | 1996-05-09 |
| NO954455D0 (no) | 1995-11-07 |
| DK0711560T3 (da) | 2001-09-03 |
| FI955310A0 (sv) | 1995-11-06 |
| ES2160145T3 (es) | 2001-11-01 |
| PT711560E (pt) | 2001-10-30 |
| AU706027B2 (en) | 1999-06-10 |
| JP3022952B2 (ja) | 2000-03-21 |
| FR2726469B1 (fr) | 1996-12-13 |
| CA2162299C (fr) | 2008-09-09 |
| FR2726469A1 (fr) | 1996-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO311402B1 (no) | Farmasöytiske preparater for oral administrasjon av flavonoider og fremgangsmåte ved fremstilling derav | |
| US9381190B2 (en) | Melatonin tablet and methods of preparation and use | |
| JP4365107B2 (ja) | 医薬組成物 | |
| JP4365106B2 (ja) | 医薬配合剤 | |
| ES2254569T3 (es) | Composicion farmaceutica de fenofibrato que presenta una biodisponibilidad elevada, y metodo para su preparacion. | |
| CA2703971C (en) | Stabilized pediatric suspension of carisbamate | |
| KR20010034718A (ko) | 속붕해성 고형 세티리진 제형 | |
| US20100209511A1 (en) | sustained release pharmaceutical formulation | |
| JP2007517011A (ja) | 経口デリバリーのための多粒子製剤 | |
| JPH07112973B2 (ja) | イブプロフェン又はその塩を活物質とする可溶性の消炎性組成物及びその製造方法 | |
| JP2007131561A (ja) | 経口固形製剤及びその製造法 | |
| KR20100034057A (ko) | 쓴맛이 저감된 프란루카스트 수화물을 함유하는 제제 | |
| JPH09286726A (ja) | 経口液剤 | |
| EP2566449A2 (en) | Pharmaceutical compositions comprising ceftibuten | |
| Vivien et al. | Nasal absorption of metoclopramide administered to man | |
| JP2001019639A (ja) | 感冒固形製剤 | |
| EP2481395A1 (en) | Sachet, effervescent tablet and dry syrup of otilonium | |
| WO2013098399A1 (en) | Mozavaptan formulations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |